There are also reports of strong evidence of systemic thrombophilia and microvascular injury associated with elevated plasma levels of C5d and endothelial deposits of C5b-9 in patients with COVID-19 (34). The gene discussed is C5; the disease is Rare hereditary thrombophilia.